Resomelagon
- Generic Name
- Resomelagon
Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)
Phase 2
Not yet recruiting
- Conditions
- Dengue Fever
- Interventions
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Federal University of Minas Gerais
- Target Recruit Count
- 120
- Registration Number
- NCT06917001
- Locations
- 🇧🇷
Clinical Research Unit, Belo Horizonte, MG, Brazil
🇧🇷Centro Integrado de Pesquisa, São José do Rio Preto, São Paulo, Brazil
A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease
Phase 2
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- SynAct Pharma Aps
- Target Recruit Count
- 105
- Registration Number
- NCT04004429
- Locations
- 🇩🇰
Aarhus Universitetshospital, Aarhus, Denmark
🇳🇴Diakonhjemmet Sykehus, Oslo, Norway
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath